Learn / GENB
NASDAQ: GENB
Generate Biomedicines (GENB) stock, explained like you're 5
Generate Biomedicines trades on the Nasdaq under the ticker GENB. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
- Ticker
- GENB
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.8 billion dollars
Is Generate Biomedicines a small, medium or large cap company?
No. Generate Biomedicines is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Generate Biomedicines makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves GENB stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Generate Biomedicines, Inc. (GENB) stock price, news, quote and history (Yahoo Finance UK)
- Generate Biomedicines (NasdaqGS:GENB) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Fund Update: New $26.6M $GENB stock position opened by BANQUE PICTET & CIE SA (Quiver Quantitative)
- Up to nearly $1.2B in milestones is tied to Generate's planned AI research on obesity drugs. (Stock Titan)
- GENB Stock Price and Chart NASDAQ:GENB (TradingView)
Follow GENB in your daily brief
Each trading day at 5 PM ET we post what happened to Generate Biomedicines and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow GENB
Questions about Generate Biomedicines stock
What does Generate Biomedicines do?
Generate Biomedicines trades on the Nasdaq under the ticker GENB. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
What is the ticker symbol for Generate Biomedicines?
Generate Biomedicines trades under the ticker GENB on the Nasdaq.
What is Generate Biomedicines's market cap?
Generate Biomedicines is a small cap stock with a market cap of about 1.8 billion dollars.
How does Generate Biomedicines make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves GENB stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow GENB stock every day?
Add GENB to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.